Related references
Note: Only part of the references are listed.Association between BTLA polymorphisms and susceptibility to esophageal squamous cell carcinoma in the Chinese population
Rui Cao et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2
Xiaozheng Xu et al.
JOURNAL OF CELL BIOLOGY (2020)
BTLA-Expressing Dendritic Cells in Patients With Tuberculosis Exhibit Reduced Production of IL-12/IFN-α and Increased Production of IL-4 and TGF-β, Favoring Th2 and Foxp3+ Treg Polarization
Jun-Ai Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease
Christoph Schultheiss et al.
IMMUNITY (2020)
Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer
Jingjing Song et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
The synergism of B and T lymphocyte attenuator (BTLA) and cytotoxic T lymphocyte associated antigen-4 (CTLA-4) attenuated acute T-cell mediated rejection and prolonged renal graft survival
Hengcheng Zhang et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2020)
HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT
Jose Ignacio Rodriguez-Barbosa et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis
Michelle A. Mintz et al.
IMMUNITY (2019)
Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy
Javier Celis-Gutierrez et al.
CELL REPORTS (2019)
BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease
Christoph Oster et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
BTLA-HVEM Checkpoint Axis Regulates Hepatic Homeostasis and Inflammation in a ConA-Induced Hepatitis Model in Zebrafish
Wei Shi et al.
JOURNAL OF IMMUNOLOGY (2019)
Investigation of BTLA tagging variants with risk of esophagogastric junction adenocarcinoma
Weifeng Tang et al.
BIOSCIENCE REPORTS (2019)
Rs1982809 is a functional biomarker for the prognosis of severe post-traumatic sepsis and MODs
Lebin Gan et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
BTLA suppress acute rejection via regulating TCR downstream signals and cytokines production in kidney transplantation and prolonged allografts survival
Jiayi Zhang et al.
SCIENTIFIC REPORTS (2019)
Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients
Qinchuan Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes
Yu-Li Chen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Expression and clinical significance of B and T lymphocyte attenuator on CD4+ and CD8+ T cells from patients with pulmonary tuberculosis
Xinghua Shen et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2019)
BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection
Xueping Yu et al.
FRONTIERS IN IMMUNOLOGY (2019)
BTLA marks a less cytotoxic T-cell subset in diffuse large B-cell lymphoma with high expression of checkpoints
Lina Quan et al.
EXPERIMENTAL HEMATOLOGY (2018)
Downregulation of BTLA on NKT Cells Promotes Tumor Immune Control in a Mouse Model of Mammary Carcinoma
Divya Sekar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illness
Sean F. Monaghan et al.
MOLECULAR MEDICINE (2018)
Distinct Changes of BTLA and HVEM Expressions in Circulating CD4+ and CD8+ T Cells in Hepatocellular Carcinoma Patients
Jiayu Liu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Not All Immune Checkpoints Are Created Equal
Annika De Sousa Linhares et al.
FRONTIERS IN IMMUNOLOGY (2018)
B- and T-Lymphocyte Attenuator Expression on Regulatory T-Cells in Patients with Severe Sepsis
Qiang Liu et al.
CHINESE MEDICAL JOURNAL (2018)
Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells
Matthieu Sawaf et al.
JCI INSIGHT (2018)
T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway
Jose-Ignacio Rodriguez-Barbosa et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer
Mathieu F. Chevalier et al.
EUROPEAN UROLOGY (2017)
Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of Mortality
Anna Lange et al.
PLOS ONE (2017)
Associations between HVEM/LIGHT/BTLA/CD160 polymorphisms and the occurrence of antibody-mediate rejection in renal transplant recipients
Zijie Wang et al.
ONCOTARGET (2017)
Adenovirus-Mediated CCR7 and BTLA Overexpression Enhances Immune Tolerance and Migration in Immature Dendritic Cells
Haiming Xin et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Antibodies targeting BTLA or TIM-3 enhance HIV-1 specific T cell responses in combination with PD-1 blockade
Katharina Grabmeier-Pfistershammer et al.
CLINICAL IMMUNOLOGY (2017)
Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter
Krit Ritthipichai et al.
CLINICAL CANCER RESEARCH (2017)
Hepatic expansion of virus-specific CD8+BTLA+ T cells with regulatory properties in chronic hepatitis B virus infection
Huaizhou Wang et al.
CELLULAR IMMUNOLOGY (2017)
Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia
Lidia Karabon et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2016)
Expression of B and T Lymphocyte Attenuator in Patients with Severe Community-Acquired Pneumonia and the Effect of Steroid Therapy in a Mouse Model
Guoqi Zhou et al.
CLINICAL LABORATORY (2016)
Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells
Andrew Jones et al.
IMMUNITY (2016)
Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis
Eduardo Huarte et al.
JOURNAL OF IMMUNOLOGY (2016)
The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis
Bin Yang et al.
PLOS ONE (2016)
ENHANCED INNATE INFLAMMATION INDUCED BY ANTI-BTLA ANTIBODY IN DUAL INSULT MODEL OF HEMORRHAGIC SHOCK/SEPSIS
Tingting Cheng et al.
SHOCK (2016)
Association of 3′ nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population
Anna Partyka et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+Lymphocytes Modulate Disease Severity
Federica Piancone et al.
SCIENTIFIC REPORTS (2016)
BTLA identifies dysfunctional PD-1-expressing CD4(+) T cells in human hepatocellular carcinoma
Qiyi Zhao et al.
ONCOIMMUNOLOGY (2016)
Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM
Yuwen Zhu et al.
SCIENCE ADVANCES (2016)
T cells from patients with Candida sepsis display a suppressive immunophenotype
Andrej Spec et al.
CRITICAL CARE (2016)
Clinical significance of tumor-infiltrating immune cells focusing on BTLA and Cbl-b in patients with gallbladder cancer
Seiji Oguro et al.
CANCER SCIENCE (2015)
Cutting Edge: The BTLA-HVEM Regulatory Pathway Interferes with Protective Immunity to Intestinal Helminth Infection
Minka Breloer et al.
JOURNAL OF IMMUNOLOGY (2015)
BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine
Senthil Kannan et al.
ONCOTARGET (2015)
Beyond CTLA-4 and PD-1, the generation Z of negative checkpoint regulators
Isabelle Le Mercier et al.
FRONTIERS IN IMMUNOLOGY (2015)
BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties
Cara L. Haymaker et al.
ONCOIMMUNOLOGY (2015)
Low B and T lymphocyte attenuator expression on CD4+ T cells in the early stage of sepsis is associated with the severity and mortality of septic patients: a prospective cohort study
Rui Shao et al.
CRITICAL CARE (2015)
A BTLA-Mediated Bait and Switch Strategy Permits Listeria Expansion in CD8α+ DCs to Promote Long-Term T Cell Responses
Xuanming Yang et al.
CELL HOST & MICROBE (2014)
An Agonistic Anti-BTLA mAb ( 3C10) Induced Generation of IL-10-Dependent Regulatory CD4+T Cells and Prolongation of Murine Cardiac Allograft
Masateru Uchiyama et al.
TRANSPLANTATION (2014)
The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells
Julie Gertner-Dardenne et al.
BLOOD (2013)
Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3
Chengying Yang et al.
GUT (2013)
The Inhibitory Receptor BTLA Controls γδ T Cell Homeostasis and Inflammatory Responses
Vasileios Bekiaris et al.
IMMUNITY (2013)
B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function
Gang Cai et al.
JOURNAL OF GASTROENTEROLOGY (2013)
CD160 Activation by Herpesvirus Entry Mediator Augments Inflammatory Cytokine Production and Cytolytic Function by NK Cells
John R. Sedy et al.
JOURNAL OF IMMUNOLOGY (2013)
Therapeutic Potential of B and T Lymphocyte Attenuator Expressed on CD8+ T Cells for Contact Hypersensitivity
Daiki Nakagomi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells
Marie-Laure Thibult et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
CD8 T Cell Memory to a Viral Pathogen Requires Trans Cosignaling between HVEM and BTLA
Rachel Flynn et al.
PLOS ONE (2013)
BTLA Interaction with HVEM Expressed on CD8+ T Cells Promotes Survival and Memory Generation in Response to a Bacterial Infection
Marcos W. Steinberg et al.
PLOS ONE (2013)
B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells
Yoshihisa Kobayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
B and T lymphocyte attenuator expression on CD4(+) T-cells associates with sepsis and subsequent infections in ICU patients
Nicholas J. Shubin et al.
CRITICAL CARE (2013)
CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1
Julien Fourcade et al.
CANCER RESEARCH (2012)
Selective Blockade of Herpesvirus Entry Mediator-B and T Lymphocyte Attenuator Pathway Ameliorates Acute Graft-versus-Host Reaction
Maria-Luisa del Rio et al.
JOURNAL OF IMMUNOLOGY (2012)
BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction
Nicholas J. Shubin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway
Yukimi Sakoda et al.
BLOOD (2011)
A Functional Polymorphism in B and T Lymphocyte Attenuator Is Associated with Susceptibility to Rheumatoid Arthritis
Mie Oki et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
Monoclonal antibodies to B and T lymphocyte attenuator (BTLA) have no effect on in vitro B cell proliferation and act to inhibit in vitro T cell proliferation when presented in a cis, but not trans, format relative to the activating stimulus
M. Zhang et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Lack of B and T lymphocyte attenuator exacerbates autoimmune disorders and induces Fas-independent liver injury in MRL-lpr/lpr mice
Yoshihiro Oya et al.
INTERNATIONAL IMMUNOLOGY (2011)
B and T Lymphocyte Attenuator Restricts the Protective Immune Response against Experimental Malaria
Guido Adler et al.
JOURNAL OF IMMUNOLOGY (2011)
Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling
Jr-Wen Shui et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
B- and T-Lymphocyte Attenuator Targeting Protects Against the Acute Phase of Graft Versus Host Reaction by Inhibiting Donor Anti-Host Cytotoxicity
Maria-Luisa del Rio et al.
TRANSPLANTATION (2011)
Dendritic cells expressing BTLA induces CD8+ T cell tolerance and attenuates the severity of diabetes
Shufa Li et al.
VACCINE (2011)
Slow Down and Survive: Enigmatic Immunoregulation by BTLA and HVEM
Theresa L. Murphy et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang Province
Zhenkun Fu et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants
Maria-Luisa del Rio et al.
IMMUNOBIOLOGY (2010)
BTLA mediates inhibition of human tumor-specific CD8(+) T cells that can be partially reversed by vaccination
Laurent Derre et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression
Joern C. Albring et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
B and T Lymphocyte Attenuator Suppresses IL-21 Production from Follicular Th Cells and Subsequent Humoral Immune Responses
Daisuke Kashiwakuma et al.
JOURNAL OF IMMUNOLOGY (2010)
B and T Lymphocyte Attenuator Is Highly Expressed on CMV-Specific T Cells during Infection and Regulates Their Function
Nacer-Eddine Serriari et al.
JOURNAL OF IMMUNOLOGY (2010)
The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation
Guifang Cai et al.
IMMUNOLOGICAL REVIEWS (2009)
Association study between B- and T-lymphocyte attenuator gene and type 1 diabetes mellitus or systemic lupus erythematosus in the Japanese population
M. Inuo et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2009)
Cutting Edge: B and T Lymphocyte Attenuator Signaling on NKT Cells Inhibits Cytokine Release and Tissue Injury in Early Immune Responses
Mendy L. Miller et al.
JOURNAL OF IMMUNOLOGY (2009)
B and T Lymphocyte Attenuator Regulates B Cell Receptor Signaling by Targeting Syk and BLNK
Andrew C. Vendel et al.
JOURNAL OF IMMUNOLOGY (2009)
Cutting Edge: A Critical Role of B and T Lymphocyte Attenuator in Peripheral T Cell Tolerance Induction
Xikui Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
B and T Lymphocyte Attenuator Tempers Early Infection Immunity
Yonglian Sun et al.
JOURNAL OF IMMUNOLOGY (2009)
T Cell Intrinsic Heterodimeric Complexes between HVEM and BTLA Determine Receptivity to the Surrounding Microenvironment
Timothy C. Cheung et al.
JOURNAL OF IMMUNOLOGY (2009)
BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice
Wayne Truong et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator
Yoshihiro Oya et al.
ARTHRITIS AND RHEUMATISM (2008)
A crucial role for HVEM and BTLA in preventing intestinal inflammation
Marcos W. Steinberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
B and T lymphocyte attenuator regulates T cell survival in the lung
Christine Deppong et al.
JOURNAL OF IMMUNOLOGY (2008)
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator
Guifang Cai et al.
NATURE IMMUNOLOGY (2008)
The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin beta receptor signaling to achieve homeostasis of dendritic cells
Carl De Trez et al.
JOURNAL OF IMMUNOLOGY (2008)
Combined coinhibitory and costimulatory modulation with Anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts
W. Truong et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival
Wayne Truong et al.
TRANSPLANTATION (2007)
Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malarial
Bernd Lepenies et al.
JOURNAL OF IMMUNOLOGY (2007)
Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells
X.-F. Wang et al.
TISSUE ANTIGENS (2007)
B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation
Carsten Krieg et al.
NATURE IMMUNOLOGY (2007)
Association of a BTLA gene polymorphism with the risk of rheumatoid arthritis
Shih-Chang Lin et al.
JOURNAL OF BIOMEDICAL SCIENCE (2006)
Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA
Maya Gavrieli et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells
Noriko Otsuki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation
Christine Deppong et al.
JOURNAL OF IMMUNOLOGY (2006)
B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs
Jens M. Chemnitz et al.
JOURNAL OF IMMUNOLOGY (2006)
Balancing co-stimulation and inhibition with BTLA and HVEM
Kenneth M. Murphy et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Attenuating lymphocyte activity - The crystal structure of the BTLA-HVEM complex
DM Compaan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells
C Krieg et al.
JOURNAL OF IMMUNOLOGY (2005)
Differential effects of B and T lymphocyte attenutator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts
R Tao et al.
JOURNAL OF IMMUNOLOGY (2005)
B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly induced in anergic CD4+ T cells
MA Hurchla et al.
JOURNAL OF IMMUNOLOGY (2005)
A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator
LC Gonzalez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator
JR Sedy et al.
NATURE IMMUNOLOGY (2005)
An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection
P Han et al.
JOURNAL OF IMMUNOLOGY (2004)
Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2
M Gavrieli et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
N Watanabe et al.
NATURE IMMUNOLOGY (2003)
Share Paper
